Ampath Chats

Vitamin D Overview

Ampath Chats
Vitamin D Overview
Read Document

PATHCHAT Edition No. 44
June 2017
Please contact your local Ampath pathologist for more information.

Author: Dr. Marita du Plessis

Vitamin D: Revised Cut-Offs for Adequacy

New Ampath Cut-Offs for Vitamin D Status (Based on Institute of Medicine & NOFSA Guidelines):

  • Deficient: <12 ng/mL
  • Insufficient: 12–19 ng/mL
  • Sufficient: ≥20 ng/mL

📌 These new cut-offs align with recommendations from the National Osteoporosis Foundation of South Africa (NOFSA) and the Institute of Medicine (IOM).

Prevalence of Vitamin D Deficiency

🔹 Global Data:

  • 41.6% of US adults (aged 20+) have vitamin D levels below 20 ng/mL (NHANES 2005–2006).

🔹 South African Data:

  • 41% of tested samples at Tygerberg Hospital had vitamin D levels below 15 ng/mL.
  • NHLS study in Johannesburg:
    • 28.6% of Indian patients had levels below 12 ng/mL.
    • Only ~5% of Black African patients had levels below 12 ng/mL.

📌 Ethnic, seasonal, and gender differences influence vitamin D levels in South Africa.

Vitamin D & Health

Primary Function of Vitamin D:

  • Maintains calcium and phosphate homeostasis.
  • Essential for bone mineralization and skeletal health.

Potential Extraskeletal Benefits (Not Yet Conclusively Proven):

  • Immune system regulation.
  • Cardiovascular health.
  • Reduced risk of cancers, diabetes, and autoimmune diseases.

📌 Vitamin D's strongest proven role remains in bone health, reducing fracture risk and osteoporosis progression.

Sources of Vitamin D

1. Sunlight (Main Source)

  • UVB exposure converts 7-dehydrocholesterol to vitamin D3 (cholecalciferol).
  • Factors influencing synthesis:
    • Season & latitude.
    • Skin pigmentation.
    • Indoor lifestyles.
    • Sunscreen & clothing habits.

2. Dietary Sources (Limited Contribution)

  • Fatty fish (salmon, sardines, tuna).
  • Fortified dairy products, cereals, and infant formula.

📌 Sun exposure remains the dominant source of vitamin D, especially in regions with limited dietary fortification.

Vitamin D Metabolism & Regulation

1. Skin Synthesis:

  • UVB exposure converts 7-dehydrocholesterol to previtamin D3.
  • Heat-dependent isomerization forms vitamin D3 (cholecalciferol).

2. Liver Conversion:

  • Vitamin D3 is hydroxylated to 25-hydroxyvitamin D [25(OH)D] (calcifediol), the primary circulating form.

3. Kidney Activation:

  • 1α-hydroxylase enzyme converts 25(OH)D to 1,25-dihydroxyvitamin D (calcitriol), the biologically active form.

4. Regulation by Hormones & Feedback Mechanisms:

  • Parathyroid hormone (PTH) stimulates renal 1α-hydroxylase, increasing calcitriol levels.
  • Fibroblast growth factor 23 (FGF23) inhibits calcitriol synthesis.
  • Calcitriol negatively regulates PTH and FGF23 production.

📌 Dysregulated vitamin D metabolism contributes to conditions like hypercalcaemia in granulomatous diseases and lymphoma.

Recommended Vitamin D Levels & Guidelines

Vitamin D Adequacy (Ampath’s New Guidelines, 2017):

  • Deficient: <12 ng/mL (30 nmol/L)
  • Insufficient: 12–19 ng/mL (30–49 nmol/L)
  • Sufficient: ≥20 ng/mL (50 nmol/L)

🔹 International Guidelines:

  • National Osteoporosis Foundation (NOF) & American Geriatric Society (AGS):
    • Target 30–50 ng/mL in older adults.
  • Endocrine Society (2011):
    • Deficiency: <20 ng/mL; Insufficiency: 20–29 ng/mL.

📌 Ampath now follows the IOM and NOFSA 2017 guidelines, which define sufficiency at 20 ng/mL or above.

Vitamin D Deficiency: Causes & Risk Factors

1. Inadequate Sun Exposure:

  • Limited outdoor activity.
  • Use of sunscreen & protective clothing.
  • High skin melanin content (darker skin tones).

2. Poor Dietary Intake or Absorption Issues:

  • Fat malabsorption syndromes (e.g., celiac disease, Crohn’s disease).
  • Chronic liver or kidney disease.
  • Exclusive breastfeeding without supplementation.

3. Increased Catabolism or Resistance:

  • Drugs that induce P450 enzymes (e.g., phenytoin, rifampicin, carbamazepine).
  • Nephrotic syndrome (urinary loss of vitamin D-binding protein).
  • Hereditary vitamin D resistance syndromes.

📌 High-risk groups include the elderly, pregnant women, obese individuals, and those with chronic diseases affecting vitamin D metabolism.

Vitamin D Deficiency: Diagnosis & Testing

1. Serum 25(OH)D Measurement (Gold Standard)

  • Reflects dietary & sun-derived vitamin D status.
  • NOT affected by PTH or acute calcium changes.

2. Additional Laboratory Tests (When Indicated):

  • Serum calcium, phosphate, alkaline phosphatase (ALP).
  • Parathyroid hormone (PTH) for secondary hyperparathyroidism.
  • Renal function tests (urea, creatinine) in chronic kidney disease.

📌 1,25-dihydroxyvitamin D (calcitriol) testing is reserved for specific disorders (e.g., granulomatous diseases, inherited rickets).

Vitamin D Supplementation & Treatment

Recommended Daily Allowances (RDA):

  • Adults (19–70 years): 600 IU/day.
  • Elderly (>70 years): 800 IU/day.
  • Pregnancy & lactation: 600 IU/day.
  • Obese patients, those with malabsorption, or on enzyme-inducing drugs: 2–3× standard dose.

Deficiency Treatment Guidelines:

  • Severe Deficiency (<10 ng/mL):
    • 50,000 IU Vitamin D2/D3 weekly for 6–8 weeks, then maintenance of 800 IU daily.
  • Moderate Deficiency (10–20 ng/mL):
    • 800–1,000 IU daily, re-test in 3 months.

📌 High-dose intermittent bolus therapy (>50,000 IU) increases fall risk in elderly and is not recommended.

Key Takeaways for Clinicians

Vitamin D sufficiency is now defined as ≥20 ng/mL, per IOM and NOFSA guidelines.
Sunlight exposure remains the primary vitamin D source.
High-risk groups (elderly, pregnant women, those with malabsorption) require screening.
Oral vitamin D supplementation is preferred over high-dose intermittent therapy.
Excessive vitamin D (>60 ng/mL) is associated with hypercalcaemia and increased mortality risk.